Market success of Novo Nordisk’s obesity drug likely to be delayed in Japan, says GlobalData
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
This transformation will enable GE HealthCare to build a strong foundation for business growth
Subscribe To Our Newsletter & Stay Updated